|
|
|
|
|
12.10.26 - 12:48
|
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance (Business Wire)
|
|
|
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, and its parent company, Bausch Health Companies Inc. (NYSE/TSX: BHC), today announced that Bausch + Lomb Board of Directors Chairman Thomas J. Appio has been appointed interim chief executive officer, effective immediately. Appio will continue to serve as CEO of Bausch Health while assuming leadership of Bausch + Lomb.
Appio was appointed chairman of the Bausch + Lomb Board of Directors in August 2026. The Board believes Appio's deep knowledge of the business, global leadership experience and longstanding connection to Bausch + Lomb position him well to build on the company's momentum and lead its next phase of growth.
“The opportunity to lead Bausch + Lomb is both a privilege and a responsibility that I embrace with great enthusiasm,” said Appio. “Our company is built on the strength of our people, the quality of our portfolio and a relentless commitment to serving customers and pat...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06.08.26 - 13:06
|
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board (PR Newswire)
|
|
|
LAVAL, QC, Aug. 6, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) ("Bausch Health" or the "Company"), today announced that its CEO, Thomas J. Appio, has been appointed to the board of directors of Bausch + Lomb Corporation (NYSE: BLCO)(TSX: BLCO), a subsidiary of......
|
|
|
06.08.26 - 13:06
|
Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance (Business Wire)
|
|
|
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced changes to its Board of Directors.
At the request of Bausch Health Companies Inc. (“Bausch Health”), which has held a majority ownership position in Bausch + Lomb since its initial public offering in 2022 and currently owns, directly or indirectly through its wholly owned subsidiaries, approximately 87% of the company's outstanding common shares, the Bausch + Lomb Board has appointed four new directors, effective Aug. 5, 2026:
Thomas J. Appio, CEO, Bausch Health
Robert Chersi, founder of Chersi Services LLC, executive director and a professor at Pace University's Center for Governance, Reporting & Regulation and a seasoned director
Laurence Paul, MD, co-founder and managing principal of Laurel Crown Partners, LLC, president of The Louis Berkman Company, minority owner of the Pittsburgh Steelers and a director of Crew...
|
|
|
31.07.26 - 05:30
|
Top Biotech Gainers: GCTK On The Move, BHC, CORT Boost FY′26 Outlook, NEOG On Watch (RTTNews)
|
|
|
Today's top gainers included Glucotrack, whose subsidiary announced progress in the development strategy for LT-100, a novel non-narcotic therapy; Nuwellis, following expanded clinical recognition for its Aquadex therapy; Bausch Health, after reporting strong second-quarter 2026 results and raising its outlook; and Corcept after posting robust second-quarter 2026 results, among others....
|
|
|
|
|
|
|
|
|
|
|
01.07.26 - 22:18
|
Michael Goettler Resigns from Bausch Health′s Board of Directors (PR Newswire)
|
|
|
LAVAL, QC, July 1, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that Michael Goettler has resigned from its Board of Directors, effective June 30, 2026, in connection with his appointment as President and Chief Executive Officer of Knoa Pharma LLC.......
|
|
|
28.05.26 - 22:18
|
Bausch Health′s Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China (PR Newswire)
|
|
|
Thermage®, a pioneer in non-invasive skin tightening, was awarded the AAA Well-Known Trademark Certification, the highest recognition in China's domestic trademark evaluation system. LAVAL, QC, May 28, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global,......
|
|
|
|